Navigation Links
Watson Reaches Settlement with Teva Over Seasonale(R)
Date:5/7/2010

MORRISTOWN, N.J., May 7 /PRNewswire-FirstCall/ -- Watson Pharmaceuticals, Inc. (NYSE: WPI) today announced that its subsidiary, Watson Laboratories, Inc. has reached a settlement with Teva Women's Health, Inc. on outstanding patent litigation related to Teva's Seasonale® (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg) product.

On December 13, 2007, Teva filed a patent infringement lawsuit against Watson in the United States District Court for the District of New Jersey involving Watson's Quasense® product, which is a generic equivalent of Teva's Seasonale®.  Under terms of the settlement agreement, Teva has granted Watson a fully paid-up license to the U.S. patents covering Seasonale® and Watson will continue marketing its generic equivalent product Quasense® (levonorgestrel and ethinyl estradiol tablets USP, 0.15 mg/0.03 mg).  Watson further admits that the licensed patents are valid and enforceable.

About Watson Pharmaceuticals, Inc.

Watson Pharmaceuticals, Inc. is a leading global specialty pharmaceutical company.  The Company is engaged in the development and distribution of generic pharmaceuticals and specialized branded pharmaceutical products focused on Urology and Women's Health.  Watson has operations in many of the world's established and growing international markets.

For press release and other company information, visit Watson Pharmaceuticals' Web site at

SOURCE Watson Pharmaceuticals, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Watson Confirms EVISTA(R) Patent Challenge
2. Watson Pharmaceuticals to Webcast Annual Meeting of Stockholders on May 7th
3. Watson To Present at Bank Of America/Merrill Lynch 2010 Healthcare Conference
4. Watson Confirms Trilipix(R) Patent Challenge
5. Watson Confirms Rapamune(R) Patent Challenge
6. Watson Confirms Cenestin(R) Patent Challenge
7. Watson Says Appeals Court Affirms Concerta(R) Patent Invalid
8. Watson to Present at Barclays 2010 Global Healthcare Conference
9. Watson Receives FDA Approval for Generic Cardizem(R) LA
10. FDA Approves Watsons TRELSTAR(R) 22.5 mg, the First and Only 6-Month Intramuscular GnRH Agonist for the Palliative Treatment of Advanced Prostate Cancer
11. Watson Announces Actos(R) Patent Challenge Settlement
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/26/2014)... Using publicly released 2015 rate filings in ... five common specialty drugs. Specialty drugs have been ... costs and shortage of generic alternatives. They treat ... and are used for a broad variety of ... HealthPocket found that among 2015 Obamacare ...
(Date:8/26/2014)... ALISO VIEJO, Calif. , Aug. 26, 2014 ... ) today announced the enrollment of the first ... the efficacy, safety and tolerability of AVP-786 for ... AVP-786 is a novel investigational drug consisting of ... dose quinidine. "There are millions of ...
(Date:8/26/2014)... Calif. , Aug. 26, 2014  Based on its ... Sullivan recognizes Volpara Solutions with the 2014 North American Frost ... an innovative range of volumetric breast imaging solutions for the ... the company has steadily introduced several new solutions and has ... States , Europe , ...
Breaking Medicine Technology:2015 Platinum Plans Are Best Buy for Consumers Using Expensive Specialty Drugs 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 2Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 3Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 4Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 5Avanir Pharmaceuticals Announces Initiation of Phase II Study of AVP-786 for the Adjunctive Treatment of Major Depressive Disorder 6Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 2Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 3Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 4Frost & Sullivan Applauds Volpara Solutions' Clear Vision in Identifying the Importance of Dose Tracking and Quantitative Analytics in the Early Detection of Breast Cancer 5
... 12, 2011 Breast Imaging facilities looking ... benefit from the exceptional image quality of the Aspire™ ... Medical Systems U.S.A., Inc. Now FDA 510(k) cleared, the ... of potential abnormalities that not only assists in more ...
... 2011 Henry Schein, Inc., (NASDAQ: ... services to office-based practitioners, announced today that Steven ... will present at the Morgan Stanley Global Healthcare Conference.  The ... City.   Henry Schein,s presentation is scheduled to ...
Cached Medicine Technology:Fujifilm's Aspire HD Receives FDA Clearance 2Fujifilm's Aspire HD Receives FDA Clearance 3Henry Schein to Present at the Morgan Stanley Global Healthcare Conference 2
(Date:8/27/2014)... D.C. (PRWEB) August 27, 2014 A ... Neurosurgery discusses the importance of time in correcting coagulopathy ... focuses on a variety of anticoagulants and examines medical ... According to the research, although anticoagulants have been approved ... and systemic embolism, they are also known to affect ...
(Date:8/27/2014)... President Obama is considering Executive action ... White House initiative that supplies green cards and work ... also open a pathway to Social Security benefits, warns ... to work authorization would add new long-term liabilities to ... the target of proposals to cut the growth in ...
(Date:8/27/2014)... PCOS (Polycystic Ovarian Syndrome) affects an estimated ... for a number of health disorders and medical conditions. ... even within the medical community. Many women are suffering ... excess body fat around the waist area (truncal obesity), ... caused by PCOS. , Awareness is the first step ...
(Date:8/27/2014)... (PRWEB) August 27, 2014 ... PartnerTech AB, a major systems integration and electronics ... Cryotherapy offering the first U.S. designed and ... offered the ideal combination of manufacturing expertise, location, ... system. Impact Cryotherapy, headquartered in Atlanta, GA, offers ...
(Date:8/27/2014)... *Anyone who is interested in learning more about the clinical ... on the web ( http://www.availclinical.com ) or contact them directly at ... by fibromyalgia – a condition characterized by a broad range ... pain , Joint stiffness , Muscle ... Depression , Anxiety , While no ...
Breaking Medicine News(10 mins):Health News:Flood Law Group Comments on Recent AAICH Study 2Health News:The Senior Citizens League (TSCL) Warns: White House Action On Immigration Could Give Social Security To Known Illegals 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 2Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 3Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 4Health News:Houston 5k Supports Women With PCOS, Sponsored by Amerejuve MedSpa 5Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 2Health News:PartnerTech Inc. and Impact Cryotherapy Announce Made in America Manufacturing Initiative 3Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 2Health News:Avail Clinical Research is Looking for Qualified Individuals Who Are Interested in Participating in a Fibromyalgia Clinical Trial Near Orlando, Florida 3
... NEW YORK, March 11 In this 90 minute episode, ... out what happened,after they left treatment. Drew reveals who has ... The audience, which is comprised of,recovering addicts and fans of ... questions about what happened over the season., ...
... - Novadaq(R) Technologies Inc.,(TSX: NDQ), a developer of ... the operating room, today announced that Dr. Arun,Menawat, ... corporate story,technology and highlights, including an update on ... Co. Healthcare Conference. The conference,runs Monday, March 17 ...
... tumors by more than half, study found , , TUESDAY, ... the 60 percent of women with breast cancer whose malignancies ... letrozole (Femara) can cut risk of a recurrence by more ... initiated the drug one to seven years after they stopped ...
... TALLAHASSEE, Fla., March 11 Based on,overwhelming response, ... FSDDS,Florida Sun Defense Essay Contest have been extended ... Dermatology and Dermatologic Surgery,(FSDDS), the contest is designed ... about the importance of sun safety. Four overall,winners ...
... AARP Services Inc. and,Genworth Financial, Inc. (NYSE: ... a,new long term care insurance plan for AARP,s ... affordable alternative to traditional,long term care insurance and ... with more states anticipated., (Logo: http://www.newscom.com/cgi-bin/prnh/20070209/NYF043LOGO ...
... 11 Verathon(R) is pleased to,announce a new ... 9400,bladder volume instrument with patent-pending NeuralHarmonics(TM),Technology. Small Child ... noninvasively on children weighing less than 60 pounds ... same instrument used for adult,patients. This enhanced BladderScan(R) ...
Cached Medicine News:Health News:Novadaq to present at Cowen Healthcare Conference 2Health News:Late Use of Aromatase Inhibitor Still Effective Against Breast Cancer 2Health News:Late Use of Aromatase Inhibitor Still Effective Against Breast Cancer 3Health News:Deadline Extended for Essay Submissions to the FSDDS Sun Defense Essay Contest Throughout Florida Elementary Schools 2Health News:AARP Services Inc. and Genworth Financial Introduce New Innovative and Affordable Long Term Care Insurance Option to AARP Members 2Health News:AARP Services Inc. and Genworth Financial Introduce New Innovative and Affordable Long Term Care Insurance Option to AARP Members 3Health News:AARP Services Inc. and Genworth Financial Introduce New Innovative and Affordable Long Term Care Insurance Option to AARP Members 4Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 2Health News:Verathon Inc. Launches Enhanced BladderScan(R) Bladder Volume Instrument With Small Child Mode 3
Sterile perfluorocarbon for intraocular Application....
Sterile Silicone Oil for Intraocular Application....
Alcon offers medical grade perfluoropropane (SF6) intraocular gases for ophthalmological use....
Silikon 1000 (purified polydimethylsiloxane) is a highly purified long chain polydimethylsiloxane trimethylsiloxy terminated silicone oil. For use as a postoperative retinal tamponade during vitreore...
Medicine Products: